Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of 14.71x is 40% below its 5-year average of 24.33x, near the low end of its 5-year range (6.98x–53.96x).
As of the fiscal period ended Tuesday, June 30, 2026. 2.32% below its 12-month average of 15.05x.
Reported quarterly interest coverage; no daily interpolation.
INTEREST COVERAGE RATIO
14.71x
INTEREST COVERAGE RATIO AVG TTM
15.05x
INTEREST COVERAGE RATIO AVG 3Y
14.84x
INTEREST COVERAGE RATIO AVG 5Y
24.33x
INTEREST COVERAGE RATIO AVG 10Y
27.00x
INTEREST COVERAGE RATIO AVG 15Y
22.84x
INTEREST COVERAGE RATIO AVG 20Y
26.64x
CURRENT VS TTM AVG
-2.32%
CURRENT VS 3Y AVG
-0.91%
CURRENT VS 5Y AVG
-39.55%
CURRENT VS 10Y AVG
-45.53%
CURRENT VS 15Y AVG
-35.60%
CURRENT VS 20Y AVG
-44.80%
SECTOR MEDIAN · HEALTHCARE
6.97x
median of 77 covered companies
CURRENT VS SECTOR MEDIAN
+110.98%
vs the sector median at left
Roche Holding AG
Market Cap
$359.46B
Interest Coverage Ratio
14.71x
TTM Avg
15.05x
3Y Avg
14.84x
5Y Avg
24.33x
Market Cap
$358.76B
Interest Coverage Ratio
4.74x
TTM Avg
6.50x
3Y Avg
9.14x
5Y Avg
10.75x
Market Cap
$369.34B
Interest Coverage Ratio
17.31x
TTM Avg
16.61x
3Y Avg
13.70x
5Y Avg
12.98x
Market Cap
$455.87B
Interest Coverage Ratio
6.94x
TTM Avg
5.10x
3Y Avg
6.01x
5Y Avg
6.01x
Market Cap
$255.15B
Interest Coverage Ratio
8.11x
TTM Avg
7.03x
3Y Avg
5.51x
5Y Avg
4.49x
Market Cap
$235.85B
Interest Coverage Ratio
3.88x
TTM Avg
3.09x
3Y Avg
3.93x
5Y Avg
4.89x
Market Cap
$234.38B
Interest Coverage Ratio
5.71x
TTM Avg
5.17x
3Y Avg
6.77x
5Y Avg
10.10x
Market Cap
$205.42B
Interest Coverage Ratio
30.34x
TTM Avg
54.30x
3Y Avg
123.94x
5Y Avg
139.58x
Market Cap
$193.04B
Interest Coverage Ratio
23.60x
TTM Avg
17.46x
3Y Avg
17.67x
5Y Avg
16.77x
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Roche Holding AG (RHHBY) | $359.46B | 14.71x | 15.05x | 14.84x | 24.33x |
| UnitedHealth Group Incorporated (UNH)vs › | $358.76B | 4.74x | 6.50x | 9.14x | 10.75x |
| Merck & Co., Inc. (MRK)vs › | $369.34B | 17.31x | 16.61x | 13.70x | 12.98x |
| AbbVie Inc. (ABBV)vs › | $455.87B | 6.94x | 5.10x | 6.01x | 6.01x |
| AstraZeneca PLC (AZN)vs › | $255.15B | 8.11x | 7.03x | 5.51x | 4.49x |
| Amgen Inc. (AMGN)vs › | $235.85B | 3.88x | 3.09x | 3.93x | 4.89x |
| Thermo Fisher Scientific Inc. (TMO)vs › | $234.38B | 5.71x | 5.17x | 6.77x | 10.10x |
| Novo Nordisk A/S (NVO)vs › | $205.42B | 30.34x | 54.30x | 123.94x | 139.58x |
| Abbott Laboratories (ABT)vs › | $193.04B | 23.60x | 17.46x | 17.67x | 16.77x |
| Gilead Sciences, Inc. (GILD)vs › | $184.82B | 11.43x | 6.56x | 7.26x | 7.18x |
Interest Coverage
14.7x
Debt/Equity
0.97
Current Ratio
1.23
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2026-06-30 | 14.71x |
| 2025-12-31 | 9.59x |
| 2025-06-30 | 20.87x |
| 2024-12-31 | 6.98x |
| 2024-06-30 | 14.35x |
| 2023-12-31 | 14.04x |
| 2023-06-30 | 23.35x |
| 2022-12-31 | 22.58x |
| 2022-06-30 | 39.81x |
| 2021-12-31 | 47.38x |
| 2021-06-30 | 53.96x |
| 2020-12-31 | 37.71x |
| 2020-06-30 | 42.97x |
| 2019-12-31 | 29.66x |
| 2012-12-31 | 12.19x |
| 2012-06-30 | 7.04x |
| 2011-12-31 | 7.04x |
| 2011-06-30 | 6.82x |
| 2010-12-31 | 6.82x |
| 2010-06-30 | 5.30x |
| 2009-12-31 | 5.30x |
| 2009-06-30 | 4.90x |
| 2008-12-31 | 71.72x |
| 2008-06-30 | 58.41x |
| 2007-12-31 | 58.41x |
| 2007-06-30 | 49.50x |
| 2006-12-31 | 37.55x |
| 2006-06-30 | 36.92x |
| 2005-12-31 | 15.88x |
| 2003-12-31 | 3.09x |
| 2002-12-31 | 0.65x |
